Future of immunotherapy could be 'off-the-shelf' treatments

(University of Texas at Arlington) In a new commentary for the journal Science, an associate vice president for research at The University of Texas at Arlington argues that emerging protein-based immunotherapies could lead to highly effective "off-the-shelf" cancer treatments for more patients.